Navigation Links
New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
Date:11/16/2011

on if primary PCI was intended or at the time of secondary PCI. The primary endpoint of the analysis was a reduction in the composite of CV death, MI and stroke.

In this analysis, TIMI major non-CABG bleeding events at 15 months occurred in 3 percent of prasugrel-treated primary PCI patients and 1.9 percent of clopidogrel-treated patients (HR=1.52, p=0.13); TIMI non-CABG major or minor bleeding occurred in this patient group in 5 percent of clopidogrel-treated patients and 6 percent of prasugrel-treated patients (HR=1.33, p=0.12). In secondary PCI patients, TIMI major non-CABG bleeding events occurred in 2.5 percent of clopidogrel-treated patients and 0.9 percent of prasugrel-treated patients (HR=0.39, p=0.07); TIMI non-CABG major or minor bleeding events occurred in 5 percent of clopidogrel-treated patients compared to 3 percent of prasugrel-treated patients (HR=0.57, p=0.09).(1) TIMI major non-CABG bleeding events associated with prasugrel as compared to clopidogrel were consistent in the STEMI cohort compared to the overall trial. Within the PCI subgroup, the hazard of bleeding with primary PCI at 15 months was HR 1.52 [CI 0.87-2.65] and for secondary PCI at 15 months was HR 0.39 [CI 0.14-1.11].(1)

Overall TRITON-TIMI 38 Study Methodology

TRITON-TIMI 38 was a head-to-head study comparing Effient (60-mg loading dose [LD], followed by a 10-mg once-daily maintenance dose) plus aspirin (ASA) with Plavix (clopidogrel) (300-mg LD, followed by a 75-mg once-daily maintenance dose) plus ASA in 13,608 patients with ACS managed with percutaneous coronary intervention (PCI), a procedure to open blockages in heart arteries, including the use of coronary stenting. The median duration of study treatment was 14.5 months.(2)

The primary endpoint of the study was the combined incidence of cardiovascular death, non-fatal heart attack or non-fatal stroke in patients followed for 6-15 months following PCI. The study showed that treatment with Effie
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Triple Analysis: Leukemia, Cancer Vaccines and Peptides
2. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
3. PRA Early Phase Experts to Speak at Bioanalysis Conference
4. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response
6. Turkey Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2017
7. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
8. Molecular Devices, LLC Introduces SoftMax Pro® 6 Microplate Data Acquisition and Analysis Software With Powerful New Data Analysis and Reporting Features
9. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
10. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
11. Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  An international roster ... Saturday, May 18, in Santa Monica, Calif. ... new lung-sparing therapies for MPM, a rare form of ... affects the pleura, the lining of the chest. ... and Blood Institute, the 3rd Annual International Symposium on ...
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/24/2013)... The potential of the pulmonary route as ... has been receiving undeniable attention with the recent advances ... crucial formulation considerations for orally inhaled products together with ... in the efficiency of pulmonary delivery, and great strides ... techniques and devices in recent years. With ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... and cesarean section trials in conjunction with David ... G. Genecov, MD, FACS, FAAP to begin immediately, ... BIEL), the maker of the ActiPatch(TM), a drug free ... pulse therapy specifically designed to speed healing, today,announced world ...
... CARMEL, Israel, May 28 , - Study ... Non-Invasive,MRgFUS to Those who had Invasive Fibroid Surgery, ... Food and Drug,Administration (FDA) cleared the company to ... safety of the ExAblate(R) 2000 system utilizing,MR-guided Focused ...
Cached Medicine Technology:BioElectronics Announces Major Clinical Trials 2BioElectronics Announces Major Clinical Trials 3BioElectronics Announces Major Clinical Trials 4FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids 2FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids 3FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids 4
(Date:5/25/2013)... 25, 2013 Imagine running the air conditioner ... loss, hot air and wasted energy! If the home has ... fireplace or clothes dryer, that may be just what is ... often overlooked holes waste energy in the form of higher ... cooling loss in the home. , Drafts occur through the ...
(Date:5/25/2013)... AZ (PRWEB) May 25, 2013 An ... service page in partnership with JD Media Surge, LLC. ... methods are now available and, depending on the treatment, ... During a routine visit, the best method will be ... is performed during a visit. A special peroxide-based whitening ...
(Date:5/25/2013)... May 25, 2013 Actos lawsuit ... in U.S. District Court, Western District of Louisiana, continue ... to a Case Management Order issued on May 21st, ... of contested motions in the Actos bladder cancer litigation, ... re: Actos Product Liability Litigation, MDL No. 2299) , ...
(Date:5/25/2013)... Forney, United States (PRWEB) May 25, 2013 ... oldest and largest underground shelter company in the ... and composite underground structures for over 35 years. ... of PROTECTION, U.S. Handbook of NBC Weapon Fundamentals ... is the United States’ bible on shelter engineering. ...
(Date:5/25/2013)... May 25, 2013 On May 20, 2013 ... do not wish to discuss or plan for their eventual ... FuneralFinancials.com released a Must-Do List to help people ... Financials recommends, “Creating a personal fact sheet.” , While not ... financial information and personal data. It may include a ...
Breaking Medicine News(10 mins):Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2
... Genetic Testing IndustryWALTHAM, Mass., Feb. 2 Interleukin ... that Chief Executive Officer Lewis H. Bender will ... Financial Strategies for Molecular Diagnostics conference, taking place ... presentation is scheduled for Wednesday, February 4 at ...
... Ask for Provisions in Stimulus Package to Help ... than 57,000 new jobs, 26,800 of which will ... in the United States through the Renewable ... to Congress and the Administration by Health Care ...
... 2 AMDL, Inc. (NYSE,Alternext US: ADL), a vertically ... announced today its Chairman and CEO Mr.,Douglas MacLellan will ... (3:40 a.m.,PT) today, February 2, 2009. , ... expert on Fox Business News to,discuss the current business ...
... to Florida to Open its Doors, with Ceremonies at 103,000-Square-Foot Facility ... ... 2009 -- More than 200 community, government and science leaders celebrated ... Studies, (TPIMS) headquarters in the Florida Center for Innovation at ...
... Network" to serve Healthcare Industry , ... ... Marketing Solutions LLC today announced partnerships with several leading ... MindSet,s geoMEDICX Zip+4 and Zip code targeting tags and offer ...
... ... Denver, CO (PRWEB) February 2, 2009 -- Susan Cordts, ... in an exclusive interview with Mary Jo Nott and the BeyeNETWORK ... predict who to target with what product, identifying what media with ...
Cached Medicine News:Health News:Interleukin Genetics to Present at G-2 Reports' Molecular Diagnostic Conference 2Health News:Healthcare Sector Leaders Urge Obama, Congress to Invest in Alternative Energy and Green Jobs in Healthcare 2Health News:Healthcare Sector Leaders Urge Obama, Congress to Invest in Alternative Energy and Green Jobs in Healthcare 3Health News:AMDL Chairman & CEO Mr. Douglas MacLellan Featured on Fox Business News Monday February 2, 2009 2Health News:Torrey Pines Institute for Molecular Studies Opens New Headquarters in Florida 2Health News:Torrey Pines Institute for Molecular Studies Opens New Headquarters in Florida 3Health News:Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media 2Health News:Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media 3Health News:ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates 2Health News:ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: